Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Previous Awards

The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology.

Previous fund recipients are highlighted below:

 

2024 

Audrey Gérard and Claudia Monaco, The Kennedy Institute of Rheumatology
Exploring the relationship between the immune landscape of cancer and atherosclerotic plaques to identify targetable pathways to control tumour growth and limit atherosclerosis incidence

Adán Pinto-Fernández, The Chinese Academy of Medical Sciences Oxford InstituteTargeting ISGylation to Boost Cancer Antigenicity: A Novel Approach for Cancer Immunotherapy

Anna Schuh and Kate Ridout, Department of Oncology
Exploring Neo-Epitope Landscapes in Chronic Lymphocytic Leukaemia for Vaccine Development (funded by the NIHR Oxford BRC)

Tamsin Cargill, NDM Experimental Medicine Division
Deciphering Tumour-associated Antigen T-cell Reactivities in Hepatocellular carcinoma to identify candidate immunogens for anti-cancer vaccine development (funded by the NIHR Oxford BRC)

 

2023

Kim Midwood, The Kennedy Institute of Rheumatology

How does macrophage marker F4/80 control T cell tolerance during tumour progression? Finding new ways of taming inflammation to improve treatment options for people with cancer

David Church and Luciana Gneo, Henry Wellcome Building of Genomic Medicine

Vaccination for cancer prevention in Lynch Syndrome

Alistair Easton, Department of Oncology

Phenotyping Intra-epithelial Lymphocytes in Pre-Invasive Lesions